Fintel reports that on September 18, 2023, HC Wainwright & Co. reiterated coverage of TG Therapeutics (NASDAQ:TGTX) with a Buy recommendation. Analyst Price Forecast Suggests 191.16% Upside
Fintel reports that on September 18, 2023, Morgan Stanley maintained coverage of Caesars Entertainment (NASDAQ:CZR) with a Equal-Weight recommendation.
Fintel reports that on September 18, 2023, Citigroup maintained coverage of Delta Air Lines (NYSE:DAL) with a Buy recommendation. Analyst Price Forecast Suggests 55.78% Upside
Fintel reports that on September 18, 2023, JMP Securities reiterated coverage of Freshworks Inc (NASDAQ:FRSH) with a Market Outperform recommendation.
Fintel reports that on September 18, 2023, Barrington Research reiterated coverage of Koppers Holdings (NYSE:KOP) with a Outperform recommendation.
Fintel reports that on September 18, 2023, Mizuho maintained coverage of Southwestern Energy (NYSE:SWN) with a Neutral recommendation. Analyst Price Forecast Suggests 27.59% Upside
Fintel reports that on September 18, 2023, Cantor Fitzgerald reiterated coverage of Roivant Sciences (NASDAQ:ROIV) with a Overweight recommendation.
Fintel reports that on September 18, 2023, Northland Capital Markets initiated coverage of Ambarella (NASDAQ:AMBA) with a Outperform recommendation.
Fintel reports that on September 18, 2023, Wells Fargo maintained coverage of Caci International Inc. - Registered Shares - (NYSE:CACI) with a Overweight recommendation.
Fintel reports that on September 18, 2023, Wells Fargo maintained coverage of RTX (NYSE:RTX) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 35.51% Upside
Fintel reports that on September 18, 2023, Telsey Advisory Group reiterated coverage of Costco Wholesale (NASDAQ:COST) with a Outperform recommendation. Analyst Price Forecast Suggests 4.10% Upside
Fintel reports that on September 18, 2023, Morgan Stanley maintained coverage of Red Rock Resorts Inc - (NASDAQ:RRR) with a Overweight recommendation.
Fintel reports that on September 18, 2023, HC Wainwright & Co. initiated coverage of Anebulo Pharmaceuticals (NASDAQ:ANEB) with a Buy recommendation.